State-of-the-Art Review : Disseminated Intravascular Coagulation: Objective Criteria for Clinical and Laboratory Diagnosis and Assessment of Therapeutic Response

Bick RL , Beard JW , Baker WF A grading system to assess severity of disease and response to therapy in acute disseminated intravascular coagulation. Thromb Haemost 1993 ;69:1219.

Baker WF Clinical aspects of disseminated intravascular coagulation: a clinician's point of view. Sem Thromb Hemostas 1989;15:1.

Bick RL Disseminated intravascular coagulation and related syndromes: a clinical review . Semin Thromb Hemostas 1988;14:299.

Bick RL Disseminated intravascular coagulation. In: Bick RL , ed. Disorders of thrombosis and hemostasis: clinical and laboratory practice. Chicago: ASCP Press, 1992:137.

Bick RL , Baker WF Disseminated intravascular coagulation. Hematol Pathol 1992;6:1.

Lasch HG , Henne DL , Huth K. , Sandritter W. Pathophysiology, clinical manifestations, and therapy of consumptive coagulopathy . Am J Cardiol 1967;20:381.

Rodriquez-Erdman F. Bleeding due to increased intravascular blood coagulation: hemorrhagic syndromes caused by consumption of blood-clotting factors (consumption coagulopathies). N Engl Med 1965;273:1370.

Dubber Ahc , McNicol GP , Douglas AS Acquired hypofibrino-genemia: the "defibrination syndrome." A study of seven patients. Scott Med J 1967;12:138.

Mersky C. , Johnson AJ , Kleiner GJ , Wohl H. The defibrination syndrome: clinical features and laboratory diagnosis. Br J Haematol 1967;13;528.

Steiner PE , Lushbough CC Maternal pulmonary embolism by amniotic fluid as a cause of shock and unexplained deaths in obstetrics. JAMA 1941;117:1245.

Hafter R. , Graeff H. Molecular aspects of defibrination in a reptilase-treated case of "dead-fetus syndrome." Thromb Res 1975;7:391.

Steichele DF Consumptive coagulopathy in obstetrics and gynecology . Thromb Diath Haemorrh 1969;(suppl)36:177.

Bonnar J. , McNicol GP , Douglas AS Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 1971;1:12.

Roberts JM , May WJ Consumption coagulopathy in severe pre-eclampsia. Obstet Gynecol 1976;48:163.

Spivack JL , Sprangler DB , Bell WR Defibrination after intra-amniotic injection of hypertonic saline. N Engl J Med 1972;287:321.

Egeberg O. Blood coagulation and intravascular hemolysis. Scand J Clin Lab Invest 1962;14:217.

Krevins JR , Jackson DP , Cowley CL , Hartman RC The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man. Blood 1957;12:834.

Langdell RD , Hedgpeth EM A study of the role of hemolysis in the hemostatic defect of transfusion reactions. Thromb Diath Haemorrh 1959;3:566.

Surgenor DM Erythrocytes and blood coagulation. Thromb Diath Haemorrh 1974;32:247.

Abildgaard CF , Corrigan JJ , Seeler RA , Simone JV , Schulman I. Meningiococcemia associated with intravascular coagulation. Pediatrics 1967;40:78.

McKay DG , Muller-Berghaus G. Therapeutic implications of disseminated intravascular coagulation. Am J Cardiol 1967;20:392.

Corrigan JJ Changes in the blood coagulation system associated with septicemia. N Engl J Med 1968;279:851.

Yoshikawa T. , Tanaka R. , Guze LB Infection and disseminated intravascular coagulation . Medicine (Baltimore) 1971;50:237.

Cline MJ , Melmon KL , Davis WC , Williams HE Mechanism of endotoxin interaction with leukocytes. Br J Haematol 1968;15:539.

McKay DG , Shapiro SS Alterations in the blood coagulation system induced by bacterial endotoxin I: in vitro (generalized Schwartzman reaction). J Exp Med 1958;107:353.

Cronberg S. , Skansberg P. , Nivenios-Larsson K. Disseminated intravascular coagulation in septicemia caused by beta-hemolytic streptococci. Thromb Res 1973;3:405.

Rubenberg WL , Baker LR , McBride JA , Sevitt JA , Brain WL Intravascular coagulation in a case of clostridium perfringens septicemia: treatment by exchange transfusion and heparin. Br Med J 1967;3:271.

Gagel C. , Linder M. , Muller-Berghaus G. , Lasch H. Virus infection and blood coagulation. Thromb Diath Haemorrh 1970 ;23: 1.

McKay DG , Margaretten W. Disseminated intravascular coagulation in virus diseases. Arch Intern Med 1967;120: 129.

Salmon SJ , Lambert PH , Louis J. Pathogenesis of the intravascular coagulation syndrome induced by immunological reactions. Thromb Diath Haemorrh 1971;45:161.

Bick RL Hemostasis in malignancy. In: Bick RL (ed). Disorders of thrombosis and hemostasis: clinical and laboratory practice. Chicago: ASCP Press, 1992:239.

Bick RL Coagulation abnormalities in malignancy. Semin Thromb Hemostas 1992;18:353.

Bick RL Alterations of hemostasis in malignancy. In: Bick RL , Bennett JM , Brynes RK. eds. Hematology: clinical and laboratory practice. St. Louis; Mosby, 1993:1583.

Brown RC , Campbell D. , Thompson J. Increased fibrinolysis with malignant disease. Arch Intern Med 1962;109:128.

Silverstein MH Agnogenic myeloid metaplasia. Action, MA: Publishing Sciences Group, 1975:10.

Mersky C. Altered blood coagulability in patients with malignant tumors. Ann NY Acad Sci 1974;23:289.

Hartman RC , Jenkins DE Proxysmal nocturnal hemoglobinuria ; current concepts of certain pathophysiological features. Blood 1965;25:850.

Holder LA , Malin LL , Fox CL Hypercoagulability after thermal injuries. Surgery 1963;54:316.

Saliba MJ , Demsey WL , Kruggel JL Large bums in humans; treatment with heparin. JAMA 1973;225:261.

Al-Mondhiry H. Disseminated intravascular coagulation: experience in a major cancer center. Thromb Diath Haemorrh 1975;34:181.

Aoki N. , Moroi M. , Matsuda M. The behavior of alpha-2-plasmin inhibitor in fibrinolytic states. J Clin Invest 1977; 60:361.

Olson JD , Kaufman H. , Moake J. , Hoots K. , Wagner K. , Brown C. , Gildenberg P. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery 1989;24:825.

Touho H. , Hirakawa K. , Hino A. , Karasawa J. , Ohno Y. Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury. Neurosurgery 1986;19:523.

Bick RL Hereditary hemorrhagic telangiectasia and disseminated intravascular coagulation: a new clinical syndrome. In: Walz DA, McCoy LE, eds. Contributions to hemostasis . Ann NY Acad Sci 1981;370:851.

Inceman S. , Tangun Y. Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia. Am J Med 1969;46:997.

Kasabach HH , Merritt KK Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940;59: 1063.

Kaxmier FJ , Didisheim P. , Fairbanks VK , Ludwig J. , Payne WS , Bowie Ejw. Intravascular coagulation and arterial disease. Thromb Diath Haemorrh 1969;(suppl)36:295.

Schnetzer GW , Penner JA Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm. South Med J 1973;66:264.

Owen CA , Bowie Ejw. Chronic intravascular coagulation fibrinolysis (ICF) syndromes (DIC). Semin Thromb Hemostas 1977;3:268.

Bick RL , Tse N. Hemostasis abnormalities associated with prosthetic devices and organ transplantation . Lab Med 1992;23:462.

Bick RL Alterations of hemostasis associated with surgery, cardiopulmonary bypass surgery, and prosthetic devices. In: Ratnoff OD , Forbes C , eds. Disorders of hemostasis. Philadelphia: WB Saunders, 1991:382.

Bick RL Disseminated intravascular coagulation. Hematol Oncol Clin North Am 1992;6:1259.

Muller-Berghaus G. Pathophysiologic and biochemical events in disseminated intravascular coagulation: dysregulation of procoagulant and anticoagulant pathways. Semin Thromb Hemostas 1989;15:58.

McKay DG , Margaretten W. , Csavossy I. An electron microscope study of the effects of bacterial endotoxin on the blood-vascular system. Lab Invest 1966;15:1815.

Owen CA , Bowie Ejw , Cooper HA Turnover of fibrinogen and platelets in dogs undergoing induced intravascular coagulation. Thromb Res 1973;2:251.

Latallo ZS Products of fibrin(ogen) proteolysis. Thromb Diath Haemorrh 1973(suppl)24:145.

Marder VJ , Shulman HR , Carroll WR High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physio-chemical and immunological characterization. J Biol Chem 1969;244:2111.

Marder VJ , Budzynski AZ , James HL High molecular weight derivatives of human fibrinogen produced by plasmin. III. Their NH2-terminal amino acids and comparison of the "NH 2-terminal amino disulfide knot." J Biol Chem 1972;247:4775.

Bang NU , Chang M. Soluble fibrin complexes. Semin Thromb Hemostas 1974;1:91.

Breen FA , Tullis JZ Ethanol gelation, a rapid screening test for intravascular coagulation. Ann Intern Med 1968;69: 111.

Fletcher AP , Alkjaersig N. , Fisher S. , Sherry S. The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally. J Lab Clin Med 1966;68:780.

Gurewich V. , Hutchinson E. Detection of intravascular coagulation by protamine sulfate and ethanol gelation tests. Thromb Res 1973;2:539.

Bick RL The clinical significance of fibrinogen degradation products. Semin Thromb Hemostas 1982;8:302.

Kopec M. , Wegrzynowiczy Z. , Budzynski A. , Latallo Z. , Lipinski B. , Kowalski E. Interaction of fibrinogen degradation products with platelets. Exp Biol Med 1968;3:73.

Niewiarowski S. , Regoeczi E. , Stewart G. , Senyi A. , Mustard J. Platelet interaction with polymerizing fibrin . J Clin Invest 1972;51:685.

Nilsson IM Local fibrinolysis as a mechanism for haemorrhage. Thromb Diath Haemorrh 1975;34:623.

Stormorken H. Relation of the fibrinolytic to other biological systems. Thromb Diath Haemorrh 1975;34:378.

Schreiber AD , Austen KF , Interrelationships of the fibrinolytic, coagulation, kinin generation, and complement systems. Semin Hematol 1973;6:593.

Kaplan A. , Meier H. , Mandel R. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin generation. Semin Thromb Hemostas 1976;3:6.

Bick RL , Murano G. Physiology of hemostasis. In: Bick RL , Bennett JM , Brynes RK , eds. Hematology: clinical and laboratory practice. St. Louis: Mosby, 1993:1285.

van Iwaarden F. , Bouma B. Role of high molecular weight kininogen in contact activation. Semin Thromb Hemostas 1987;13:15.

Beller FK , Theiss W. Fibrin derivatives, plasma hemoglobin and glomerular fibrin deposition in experimental intravascular coagulation. Thromb Diath Haemorrh 1973;29: 363.

McKay DG , Linder MM , Cruse VK Mechanisms of thrombosis of the microcirculation. Am J Pathol 1971 ;63: 231.

Lerner RG The defibrination syndrome. Med Clin North Am 1976;60:871.

Robboy SJ , Coleman RW , Minna JD Pathology of disseminated intravascular coagulation (DIC): analysis of 26 cases. Hum Pathol 1972;3:327.

Muller-Berghaus G. Pathophysiology of generalized intravascular coagulation. Semin Thromb Hemostas 1977;3:209.

Owen CA , Bowie Ejw. Chronic intravascular syndromes. Mayo Clin Proc 1974;49:673.

Bleyl U. Morphologic diagnosis of disseminated intravascular coagulation: histologic, histochemical, and electron-microscopic studies. Semin Thromb Hemostas 1977;3:247.

Skjorten F. Hyaline microthrombi in an autopsy material: a quantitative study with discussion of the relationship to small vessel thrombosis . Acta Pathol Microbiol Scand 1969;76:361.

Morris JA , Smith RW , Assali NS Hemodynamic action of vaso-pressor and vaso-depressor agents in endotoxin shock. Am J Obstet Gynecol 1965;91:491.

Bleyl U. , Kuhn W. , Graeff H. Reticulo-endotheliale clearance intravascaler: fibrinmonere in der milz. Thromb Diath Haemorrh 1969;22:87.

Boyd JF Disseminated fibrin-thromboembolism among neonates dying within 48 hours of birth. Arch Dis Child 1967; 42:401.

Bull B. , Kuhn IN The production of schistocytes by fibrin strands (a scanning electron microscope study). Blood 1970;35:104.

Heyes H. , Kohle W. , Slijerpcevic B. The appearance of schistocytes in the peripheral blood in correlation to degree of disseminated intravascular coagulation. Haemostasis 1976;5:66.

Bull B. , Rubenberg M. , Dacie J. , Brain MC Microangiopathic hemolytic anemia: mechanisms of red-cell fragmentation. Br J Haematol 1968;14:643.

Slaastad RA , Godal NC Coagulation profile and ethanol gelation test with special reference to components consumed during coagulation. Scand J Haematol 1976;16:25.

Bick RL Platelet defects. In: Disorders of hemostasis and thrombosis: principles of clinical practice. New York: Thieme, Inc. 1985:65.

Karpatkin S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume. Blood 1978; 51:307.

Eckhardt T. , Muller-Berghaus G. The role of blood platelets in the precipitation of soluble fibrin endotoxin. Scand J Haematol 1975;14:181.

Blaisdell FW , Stallone RJ The mechanism of pulmonary damage following traumatic shock. Surg Gynecol Obstet 1970;130:15.

Van Breeman VL , Heustein HB , Bruns PD Pulmonary hyaline membranes studied with the electron microscope. Am J Pathol 1957;33:769.

Martin AM , Soloway HB , Simmons RL Pathologic anatomy of the lungs following shock and trauma. J Trauma 1968;8:687.

Soloway HB , Castillo Y. , Martin AM Adult hyaline membrane disease. Ann Surg 1968 ;168:937.

Hardaway RM Acute respiratory distress syndrome and disseminated intravascular coagulation. South Med J 1978 ; 71:596.

Hardaway RM Syndromes of disseminated intravascular coagulation with special reference to shock and hemorrhage. Springfield, IL: Charles C. Thomas, 1966.

Muller-Berghaus G. , Mann B. Precipitation of ancrod-induced soluble fibrin by aprotinin and norepinephrine. Thromb Res 1973;2:305.

Latour JG , Prejean JB , Margaretten W. Corticosteroids and the generalized Schwartzman reaction: mechanisms of sensitization in the rabbit. Am J Pathol 1971;65:189.

Bick RL , Fekete LF , Wilson WL Treatment of disseminated intravascular coagulation with antithrombin III . Trans Am Soc Hematol 1976:167.

Bick RL Clinical hemostasis practice: the major impact of laboratory automation. Semin Thromb Hemostas 1983;9: 139.

Fareed J. New methods in hemostatic testing. In: Fareed J , Messmore HL , Fenton J , Brinkhous KM , eds. New York: Pergamon Press, 1981:310.

Messmore HL Automation in coagulation testing: clinical applications. Semin Thromb Hemostas 1983;9:335.

Bick RL Disseminated intravascular coagulation: clinical/ laboratory correlations . Am J Clin Pathol 1982;77:244.

Seegers WH , Marceniak E. Autoprothrombin C in irregular blood clotting . Thromb Diath Haemorrh 1962;8;81.

Marder VJ , Matchett MO , Sherry S. Detection of serum fibrinogen and fibrin degradation products: comparison of six techniques using purified products and application in clinical studies . Am J Med 1971;51:71.

Myers AR , Bloch KJ , Coleman RW A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med 1970; 283:663.

Gurewich V. , Lipinsky B. , Lipinska I. A comparative study of precipitation and paracoagulation by protamine sulfate and ethanol gelation tests. Thromb Res 1973;2:539.

Hedner U. , Nilsson IM Parallel determinations of FDP and fibrin monomers with various methods. Thromb Diath Haemorrh 1972;28:268.

Sonnabend D. , Cooper D. , Fiddes P. , Penny R. Fibrin degradation products in thromboembolic disease. Pathology 1972;4:47.

Kidder WR , Logan LJ , Rapaport SI , Patch MJ The plasma protamine paracoagulation test: clinical and laboratory evaluation . Am J Clin Pathol 1972;58:675.

Stibbe J. , Gomes M. , de Ouda A. The value of the FM-test (KABI) and thrombin-antithrombin-III complexes (TAT) in the management of DIC in cancer. Thromb Haemostas 1989;65:1238.

Francis CW , Marder VJ A molecular model of plasmic degradation of cross-linked fibrin. Semin Thromb Hemostas 1982;8:25.

Plow EF , Edgington TS Surface markers of fibrinogen and its physiologic derivatives related by antibody probes. Semin Thromb Hemostas 1982;8:36.

Matsumoto T. , Nishijima Y. , Teramura Y. , Fujino K. , Hibino M. , Hirata M. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain. Thromb Res 1985;38:279.

Rylatt DB , Blake AS , Cottis LE , et al. An immunoassay for human D-dimer using monoclonal antibodies . Thromb Res 1983;31:767.

Bick RL , Baker W. Diagnostic efficacy of the D-dimer assay in DIC and related disorders. Thromb Res 1992;65:785.

Lane DA , Preston FE , Van Ross ME , Kakkar VV Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Br J Haematol 1978;40:609.

Elms MJ , Bunce IH , Bundesen PG , et al. Measurement of cross-linked fibrin degradation products; an immunoassay using monoclonal antibodies. Thromb Haemostas 1983;50: 591.

Ellis DR , Eaton AS , Plank MC , Butman BT , Ebert RF A comparative evaluation of ELISA's for D-dimer and related fibrin(ogen) degradation products. Blood Coag Fibrinol 1993;4:537.

Murano G. The molecular structure of fibrinogen. Semin Thromb Hemostas 1974;1:1.

Rosenberg JS , Beeler DL , Rosenberg RD Activation of human prothrombin by highly purified human factors V and Xa in the presence of human antithrombin. J Biol Chem 1975;250:1607.

Tietel JM , Bauer KA , Lau HK , Rosenberg RD Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex . Blood 1982;59:1086.

Boneu B. , Bes G. , Pelzer H. , Sie P. , Boccalon H. D-dimers, thrombin antithrombin complexes and prothrombin fragments 1+2: diagnostic value in clinically suspected deep vein thrombosis. Thromb Haemostas 1991 ;65:28.

Bruhn HD , Conard J. , Mannucci M. , et al. Multicentric evaluation of a new assay for prothrombin fragment F 1 + 2 determination. Thromb Haemostas 1992 ;68:413.

Ceriello A. , Giacomello R. , Colatutto A. , Taboga C. , Gonano F. Increased prothrombin fragment 1 + 2 in type I diabetic patients. Haemostasis 1992;22:50.

Demers C. , Ginsberg JS , Henderson P. , Ofosu FA , Weitz JI , Blajchman MA Measurements of markers of activated coagulation in antithrombin III deficient patients. Thromb Haemostas 1992;67:542.

Okamoto K. , Takaki A. , Takeda S. , Katoh H. , Ohsato K. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 +2 and other markers. Haemostasis 1992;22:17.

Pelzer H. , Schwarz A. , Stuber W. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991;65:153.

Sorensen JV , Jensen HP , Rahr HR , Borris L. , Lassen MR , Knudsen F. F 1 + 2 and FPA in urine from patients with multiple trauma and healthy individuals: a pilot study. Thromb Res 1992;67:429.

Bick RL , Dukes ML , Wilson WL , Fekete L. Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 1977;10:721.

Bick RL Clinical relevance of antithrombin III. Semin Thromb Hemostas 1982;8:276.

Bick RL , McClain BJ A clinical comparison of chromogenic, fluorometric, and natural (fibrinogen) substrates for determination of antithrombin-III. Thromb Haemost 1981; 46:364.

Fareed J. , Messmore HL , Walenga JM , Bermes EW , Bick RL Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements. Semin Thromb Hemostas 1982;8:288.

Asakura H. , Saito M. , Ito K. , et al. Levels of thrombin-antithrombin III complex in plasma in cases of acute pro-myelocytic leukemia. Thromb Res 1988;50:895.

Cronlund M. , Hardin J. , Burton J. , Lee L. , Haber I. , Bloch KJ Fibrinopeptide-A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosis. J Clin Invest 1976;58:142.

Douglas JT , Shah M. , Lowe Gdo , Prentice Crm. Fibrinopeptide-A and beta-thromboglobulin levels in pre-eclampsia and hypertensive pregnancy. Thromb Haemostas 1981;46:8.

Bauer KA , Weiss LM , Sparrow D. , Vokonas PS , Rosenberg RD Aging-associated changes in indices of thrombin generation and protein C activation in humans: normative aging study. J Clin Invest 1987;80:1527.

Fareed J. , Bick RL , Walenga J. , Messmore HL , Bermes EW Clinical and experimental studies using a modified radioimmunoassay for B-beta 15-42 related peptides. Thromb Haemostas 1983 ;50:300.

Fareed J. , Bick RL , Squillaci G. , Walenga J. , Messmore HL , Bermes EW Clinical and experimental utilization of a modified radioimmunoassay for B-beta 15-42 related peptides. Clin Chem 1983;29:1161.

Harpel PC Alpha-2-plasmin inhibitor and alpha-2-macroglobulin-plasmin complexes in plasma . J Clin Invest 1981 ;68:46.

Clavin SA , Bobbitt JL , Shuman RT , Smithwick EL Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin. Anal Biochem 1977;80:355.

Triplett DA , Harms C. , Hermelin L. , Huseby RM , Mitchell GA , Pochron SP Clinical studies of the use of fluorogenic substrate assay method for the determination of plasminogen. Thromb Haemostas 1979;42:50.

Kowalski E. , Kopec M. , Niewiarowski S. An evaluation of the euglobulin method for the determination of fibrinolysis. J Clin Pathol 1959;12:215.

Menon IS A study of the possible correlation of euglobulin lysis time and dilute blood clot lysis time in the determination of fibrinolytic activity. Lab Pract 1968;17:334.

Collen P. Identification and some properties of a new fast-acting plasmin inhibitor in human plasma. Eur J Biochem 1976;69:209.

Harpel PC , Mosesson MW , Cooper NR Studies on the structure and function of alpha-2-macroglobulin and C1 inactivator . In: Reich E , Rifkin DB , Shaw E , eds. Proteases and biological control. Cold Spring Harbor: Cold Spring Harbor Symposium 1975:387.

Takahashi H. , Koike T. , Yoshida N. , et al. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha-2 plasmin inhibitor complex and von Willebrand factor fragment in plasma. Am J Hematol 1986;23:153.

Wiman B. , Jacobsson L. , Andersson M. , Mellbring G. Determination of plasmin-alpha-2-plasmin inhibitor complex in plasmas samples by means of a radioimmunoassay. Scand J Clin Lab Invest 1983;43:27.

Takahashi H. , Hanano M. , Takizawa S. , Tatewaki W. , Shibata A. Plasmin-alpha-2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation. Am J Hematol 1988;28:162.

Matsuda T. , Seki T. , Ogawara M. , Miura R. , Yokouchi M. , Murakami M. Comparison between plasma levels of B-thromboglobulin and platelet factor 4 in various diseases. Thromb Haemostas 1979;42:288.

Zahavi J. , Kakkar VV B-thromboglobulin: a specific marker of in vivo platelet release reaction . Thromb Haemostas 1980;44:23.

Kwaan HC Disseminated intravascular coagulation. Med Clin North Am 1972;56;177.

Bick RL Disseminated intravascular coagulation: objective criteria for diagnosis and management. Med Clin North Am 1994;78:511.

Bick RL Clinical implications of molecular markers in hemostasis and thrombosis. Semin Thromb Hemostas 1984; 10:252.

Feinstein DI Treatment of disseminated intravascular coagulation . Semin Thromb Hemostasis 1988;14:351.

Heene DL Blood coagulation mechanism and endotoxins: hemostatic defect in septic shock . In: Urbaschek B , ed. Gram-negative bacterial infections and mode of endotoxin actions. Vienna: Springer-Verlag, 1975:367.

Leroy J. , Lamagnere JD , Mercier C. La coagulopathie de consommation au cours des purpuras fulminans et son traitment (10 observations). Semin Hôp Paris 1974;50:843.

Lo SS , Hitzig WH , Frick PG Clinical experience with anticoagulant therapy in the management of disseminated intravascular coagulation in children. Acta Haematol 1971; 45:1.

Corrigan JJ , Jordan CM Heparin therapy in septicemia with disseminated intravascular coagulation: effect on mortality and correction of hemostatic defects. N Engl J Med 1970;283:778.

Good RA , Thomas L. Studies on the generalized Schwartzman reaction: prevention of the local and generalized Schwartzman reactions with heparin. J Exp Med 1953;97: 871.

Heene DL Disseminated intravascular coagulation: evaluation of therapeutic approaches . Semin Thromb Hemost 1977;3:291.

Bick RL Disseminated intravascular coagulation: a clinical/laboratory study of 48 patients. In: Walz D, McCoy L, eds. Contributions to hemostasis . Ann NY Acad Sci 1981; 370:843.

Kuhn W. , Graeft H. Gerinnungsstorungen in der Geburtshilfe. Stuttgart: Theime Verlag, 1977:90.

Minna JD , Robboy S. , Coleman RW Clinical approach to a patient with suspected DIC. In: Minna JD , Robboy S , Coleman RW , eds. Disseminated intravascular coagulation. Springfield, IL: Charles C. Thomas, 1974:167.

Thaler E. , Lechner K. Antithrombin III deficiency and thromboembolism. Clin Haematol 1981;10:369.

Bentley PG , Kakkar VV , Scully MF , MacGregor IR , Webb P. , Chan P. An objective study of alternative methods of heparin administration. Thromb Res 1980 ;18:177.

Jaques LB The premises involved in the clinical use of heparin. Semin Thromb Hemostas 1978;4:275.

Markwardt F. Development of hirudin as an antithrombotic agent. Semin Thromb Hemostas 1989;15:269.

Fourrier F. , Chopin C. , Huart J. , Runge I. , Caron C. , Goudemand J. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation. Chest 1993;104:882.

Talbot M. Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis. Semin Thromb Hemostas 1989;15:293.

Niada R. , Prota R. , Pescador R. , Mantovani M. , Prino G. Thrombolytic activity of defibrotide against old venous thrombi. Semin Thromb Hemostas 1989;15:474.

Ulutin ON Clinical effectiveness of defibrotide in vasoocclusive disorders and its mode of action. Semin Thromb Hemostas 1988;14:58.

Umeki S. , Adachi M. , Watanabe M. , Yaji S. , Soejima R. Gabexate as a therapy for disseminated intravascular coagulation. Arch Intern Med 1988;148;1409.

Bick RL , Schmalhorst WR , Fekete LF Disseminated intravascular coagulation and blood component therapy. Transfusion (Philadelphia) 1976;16:361.

Avvisati G. , Buller HR , Wouter Ten Cate J, Mandelli F. Tranexamic acid for control of haemorrhage in acute pro-myelocytic leukemia. Lancet 1989;2:122.

Schwartz BS , Williams EC , Conlan MG , Mosher D. Epsilon-aminocaproic acid in the treatment of acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency . Ann Intern Med 1986;105:873.

Gralnick HR , Greipp P. Thrombosis with epsilon-aminocaproic acid therapy. Am J Clin Pathol 1971 ;56:151.

McNicol GP , Douglas AS Thrombolytic therapy and fibrinolytic inhibitors. In: Human blood coagulation, haemostasis, and thrombosis. London . Oxford Press, 1972:393.

Ratnoff OD Epsilon aminocaproic acid: a dangerous weapon . N Engl J Med 1969;280:1124.

Patterson WP , Ringenberg QS The pathophysiology of thrombosis in cancer . Semin Oncol 1990;17:140.

Bick RL Alterations of hemostasis in malignancy. In: Bick RL , ed. Disorders of hemostasis and thrombosis: principles of clinical practice. New York: Thieme, Inc., 1985:262.

Goodnight SH Bleeding and intravascular clotting malignancy: a review. Ann NY Acad Sci 1974;230:271.